Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1996-03-26
1999-04-20
Wortman, Donna C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242341, 4242781, 4242821, 4242831, A61K 3912, A61K 3326
Patent
active
058956530
ABSTRACT:
An adjuvant is described which comprises an iron compound in colloidal form as well as a pharmaceutical composition which comprises this adjuvant together with at least a protein and/or peptide and/or polysaccharide and/or a nucleic acid derived from a virus, bacterium and/or a parasite.
The adjuvant according to the invention and the pharmaceutical composition comprising this adjuvant are suitable for prophylactic or therapeutic treatment of illnesses caused by various pathogens.
REFERENCES:
patent: Re35338 (1996-09-01), Haynes
patent: 4313734 (1982-02-01), Leuvering
patent: 4452773 (1984-06-01), Molday
patent: 4951675 (1990-08-01), Groman et al.
patent: 5178882 (1993-01-01), Kossovsky et al.
Mancini Et Al., Immunochemistry, vol. 2, pp. 235-254 (1965).
Nakamura Et Al., Nature, vol. 307, pp. 381-382 (Jan. 26, 1984).
Good Et Al., J. of Immunology, vol. 141(3):972-977 (Aug. 1, 1988).
Gemant, A., Iron hydroxide: Model for enzymes that oxidize proteins. Molec. Biol. Rep. 4(2):121-125, 1978.
Eibl Johann
Leibl Heinz
Mannhalter Josef
Chen Tony D.
Fong Jerry
Rozsa Thomas I.
Tempo G
Wortman Donna C.
LandOfFree
Adjuvant based on colloidal iron compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adjuvant based on colloidal iron compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant based on colloidal iron compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2246561